Literature DB >> 3357877

The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells.

H Y Tung1, W J Bargmann, M Y Lim, H R Bose.   

Abstract

The transforming protein encoded by the v-rel oncogene of avian reticuloendotheliosis virus (REV-T) is a very low copy number molecule in the cytosol of transformed cells. Analysis of cytosolic extracts from a REV-T-transformed lymphoid cell line by gel filtration on Sephacryl S-300 indicated that most of the v-rel oncogene product, pp59v-rel, eluted with an apparent molecular mass of 400 kDa. The size of this complex was confirmed by analysis on a fast-protein liquid chromatography gel filtration column. A 40-kDa cellular protein copurified with pp59v-rel on sequential gel filtration on Sephacryl S-200 and immunoaffinity chromatography with a monoclonal antibody directed against pp59v-rel. The 40-kDa cellular protein could also be immunoprecipitated together with pp59v-rel from cell extracts of [35S]methionine-labeled cells, suggesting that pp59v-rel is complexed with the 40-kDa protein in transformed lymphoid cells. Both the 59- and 40-kDa proteins were phosphorylated when the highly purified preparation containing pp59v-rel was incubated with [gamma-32P]ATP and 10 mM MgCl2 in vitro. The identity of the kinase in the highly purified preparation containing pp59v-rel, however, is unknown. Immune complexes recovered from extracts of REV-T-transformed lymphoid cells labeled with [32P]orthophosphate also contained the 59- and 40-kDa phosphoproteins. These observations suggest that pp59v-rel is complexed with a 40-kDa cellular phosphoprotein to form a 400-kDa heteropolymer in the cytoplasm of transformed lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357877      PMCID: PMC280020          DOI: 10.1073/pnas.85.8.2479

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Oncogene expression in reticuloendotheliosis virus-transformed lymphoid cell lines and avian tissues.

Authors:  N K Herzog; W J Bargmann; H R Bose
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells.

Authors:  N K Herzog; H R Bose
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Detection and characterization of the protein encoded by the v-rel oncogene.

Authors:  N R Rice; T D Copeland; S Simek; S Oroszlan; R V Gilden
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

4.  Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA.

Authors:  N R Rice; R R Hiebsch; M A Gonda; H R Bose; R V Gilden
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel.

Authors:  K C Wilhelmsen; K Eggleton; H M Temin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

6.  Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning.

Authors:  I S Chen; T W Mak; J J O'Rear; H M Temin
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

7.  Structure and dimorphism of c-rel (turkey), the cellular homolog to the oncogene of reticuloendotheliosis virus strain T.

Authors:  K C Wilhelmsen; H M Temin
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

8.  Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.

Authors:  R M Stephens; N R Rice; R R Hiebsch; H R Bose; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Polyoma virus transforming protein associates with the product of the c-src cellular gene.

Authors:  S A Courtneidge; A E Smith
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

10.  The complex of polyoma virus middle-T antigen and pp60c-src.

Authors:  S A Courtneidge; A E Smith
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  10 in total

1.  In vivo self-association of the Drosophila rel-protein dorsal.

Authors:  S Govind; A M Whalen; R Steward
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

3.  Avian reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59v-rel complexes.

Authors:  N Davis; W Bargmann; M Y Lim; H Bose
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Autoregulation of I kappa B alpha activity.

Authors:  P J Chiao; S Miyamoto; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

5.  p59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells.

Authors:  S Simek; N R Rice
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Characterization of a novel promoter insertion in the c-rel locus.

Authors:  N Kabrun; N Bumstead; M J Hayman; P J Enrietto
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

7.  Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.

Authors:  C Chen; F Agnès; C Gélinas
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  NF-kappa B/Rel family members are physically associated phosphoproteins.

Authors:  C C Li; M Korner; D K Ferris; E Chen; R M Dai; D L Longo
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel.

Authors:  T H Tan; G P Huang; A Sica; P Ghosh; H A Young; D L Longo; N R Rice
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

10.  The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.

Authors:  H C Liou; G P Nolan; S Ghosh; T Fujita; D Baltimore
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.